Thomas K. Nordt - Concepedia

Author

Thomas K. Nordt

Heidelberg University

Also Known As

Andreas Zirlik, Esther Eschenfelder, T Nordt, Thomas K Nordt, Thomas K. Nordt, Thomas Nordt, Thomas Nordt MD

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University University of Freiburg Washington University in St. Louis University of Vermont Chirurgische Universitätsklinik Heidelberg

About

Thomas K. Nordt is an author at Heidelberg University specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	361
2	Cell Biology	4	4	288
3	Biomedical Engineering	2	2	49
4	Natural Sciences	1	1	10
5	Biomolecular Engineering	1	1	10

Thomas K. Nordt

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Circulating Vascular Cell Adhesion Molecule-1 Correlates With the Extent of Human Atherosclerosis in Contrast to Circulating Intercellular Adhesion Molecule-1, E-Selectin, P-Selectin, and Thrombomodulin Karlheinz Peter, Peter P. Nawroth, Christian Conradt, Arteriosclerosis Thrombosis and Vascular Biology	1997	305
Induction of Fibrinogen Binding and Platelet Aggregation as a Potential Intrinsic Property of Various Glycoprotein IIb/IIIa (IIbβ3) Inhibitors Karlheinz Peter, Meike Schwarz, Jari Ylänne, Blood	1998	228
Elaboration of Type-1 Plasminogen Activator Inhibitor From Adipocytes Craig H. Lundgren, Steven L. Brown, Thomas K. Nordt, Circulation	1996	224
Induction of Plasminogen Activator Inhibitor Type-1 (PAI-1) by Proinsulin and Insulin In Vivo Thomas K. Nordt, Hirofumi Sawa, Satoshi Fujii, Circulation	1995	186
Heparin Inhibits Ligand Binding to the Leukocyte Integrin Mac-1 (CD11b/CD18) Karlheinz Peter, Meike Schwarz, Christian Conradt, Circulation	1999	124
Stimulation by Proinsulin of Expression of Plasminogen Activator Inhibitor Type-I in Endothelial Cells David J. Schneider, Thomas K. Nordt, Burton E. Sobel Diabetes Endothelial CellsInsulinlike Growth FactorTyrosine KinaseImmunologyInsulin Receptor	1992	120
The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, αMβ2) Meike Schwarz, Thomas K. Nordt, Christoph Bode, Thrombosis Research InflammationVarious LigandsAnti-inflammatoryMedicineImmunology	2002	83
Platelet Function During and After Thrombolytic Therapy for Acute Myocardial Infarction With Reteplase, Alteplase, or Streptokinase Martin Moser, Thomas K. Nordt, Karlheinz Peter, Circulation	1999	68
Oxidative Stress and Atherosclerosis: Its Relationship to Growth Factors, Thrombus Formation and Therapeutic Approaches Karlheinz Peter, W Kübler, Johannes Ruef, Thrombosis and Haemostasis	1999	66
Flow Cytometric Monitoring of Glycoprotein IIb/IIIa Blockade and Platelet Function in Patients With Acute Myocardial Infarction Receiving Reteplase, Abciximab, and Ticlopidine Karlheinz Peter, Benedikt Köhler, Andreas Straub, Circulation	2000	56

Page 1